Patients are responsible for self-injecting the medicine in the comfort of their homes
A thorough examination can determine if the pain is from the spine, nerves, muscles, or SI joint, making professional evaluation valuable
While both medications are revolutionary tools for chronic weight management, they belong to the same pharmacological class of GLP-1 receptor agonists
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
Yes variants in GLP1R, GIPR, FTO, MC4R, and TCF7L2 are associated with differential GLP-1 response
Brighten and smooth the look of uneven skin tone